Journal of Surgery Concepts & Practice >

2021 , Vol. 26 >Issue 02: 163 - 166

DOI: https://doi.org/10.16139/j.1007-9610.2021.02.014

Original article

Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of pancreaticobiliary maljunction

Expand
  • 1. Department of Gastroenterology, Affiliated Hangzhou First People's Hospital (North Campus), Zhejiang University School of Medicine, Zhejiang Hangzhou 310022, China
    2. Department of Gastroenterology Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang Hangzhou 310006, China

Received date: 2020-09-30

  Online published: 2022-07-27

Fold

Abstract

Objective To investigate the effect and safety of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis and treatment of pancreaticobiliary maljunction (PBM). Methods The patients with PBM were diagnosed and treated using ERCP and included from December 2007 to August 2020 in Hangzhou First People's Hospital of Zhejiang University School of Medicine. The clinical manifestations of PBM, ERCP treatment, and post ERCP complications were analyzed. Results A total of 219 patients with PBM were in this study including 95 males and 124 females with an average age of (52.11±23.32) (2-89) years. Abdominal pain (77.93%) was the main clinical manifestations of PBM. The success rate of endoscopy intubation was 98.17% (215/219), and the cases with curative ERCP was 96.80% (212/219). Twenty-three of ERCP(7.93%) had post ERCP complications cured all by conservative treatment. Conclusions PBM is more common in women with main manifestation of abdominal pain. ERCP is effective and safe for biliary and pancreatic diseases induced by PBM.

Key words： Endoscopic retrograde cholangiopancreatography; Pancreaticobiliary maljunction; Acute pancreatitis

Cite this article

ZHOU Haibin, JIN Hangbin, HUANG Haitao, YANG Jing, LÜ Wen, ZHANG Xiaofeng, YANG Jianfeng . Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of pancreaticobiliary maljunction[J]. Journal of Surgery Concepts & Practice, 2021 , 26(02) : 163 -166 . DOI: 10.16139/j.1007-9610.2021.02.014

References

[1] Hyvärinen I, Hukkinen M, Kivisaari R, et al. Increased prevalence of pancreaticobiliary maljunction in biliary malignancies[J]. Scand J Surg, 2019, 108(4):285-290.
[2] 胡冰, 周岱云, 吴萍, 等. 先天性胆胰管合流异常与胆囊癌的关联[J]. 中华消化内镜杂志, 2004, 21(4):8-11.
[3] 李鹏, 王拥军, 王文海. 中国ERCP指南(2018版)[J]. 中华消化内镜杂志, 2018, 35(11):777-813.
[4] Cui GX, Huang HT, Yang JF, et al. Rare variant of pancreaticobiliary maljunction associated with pancreas divisum in a child diagnosed and treated by endoscopic retrograde cholangiopancreatography: a case report[J]. World J Clin Cases, 2019, 7(9):1073-1079.
[5] Wang Q, Moon SB, Zang J, et al. Usefulness of pre-ope-rative endoscopic retrograde cholangiopancreatography in diagnosis and management of forme fruste choledochal cyst in children[J]. ANZ J Surg, 2020, 90(6):1041-1045.
[6] 汪健, 郭万亮. 儿童胰胆管合流异常诊断及治疗[J]. 肝胆外科杂志, 2012, 20(6):470-471.
[7] 吕涛, 张筱凤. 内镜下逆行胰胆管造影术在儿童胰腺疾病中的应用分析[J]. 中华儿科杂志, 2013, 51(5):367-370.
[8] Kamisawa T, Kuruma S, Chiba K, et al. Biliary carcinogenesis in pancreaticobiliary maljunction[J]. J Gastroenterol, 2017, 52(2):158-163.
[9] Kamisawa T, Honda G. Pancreaticobiliary maljunction: markedly high risk for biliary cancer[J]. Digestion, 2019, 99(2):123-125.
[10] 周进学, 李臻, 韩新巍, 等. 胰胆管汇合异常与胆道癌的关系[J]. 中华肝胆外科杂志, 2011, 17(4):341-343.
[11] 周进学, 李臻, 韩新巍, 等. 胰胆管汇合异常与胆道癌的相关性研究[J]. 中国肿瘤临床, 2010, 37(15):879-881.
[12] Kamisawa T, Funata N, Hayashi Y, et al. Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel[J]. Gastrointest Endosc, 2004, 60(1):56-60.
[13] Kamisawa T, Tu Y, Egawa N, et al. MRCP of congenital pancreaticobiliary malformation[J] Abdom Imaging, 2007, 32(1):129-133.
[14] 韩新巍, 李臻, 吴刚. 经皮肝穿刺胆道造影诊断胰胆管合流异常的价值[J]. 中华放射学杂志, 2008, 42(8):797-801.
[15] Zeng JQ, Deng ZH, Yang KH, et al. Endoscopic retrograde cholangiopancreatography in children with symptomatic pancreaticobiliary maljunction: a retrospective multicenter study[J]. World J Gastroenterol, 2019, 25(40):6107-6115.
[16] Jin Z, Bie LK, Tang YP, et al. Endoscopic therapy for patients with pancreaticobiliary maljunction: a follow-up study[J]. Oncotarget, 2017, 8(27):44860-44869.
[17] Hiramatsu T, Itoh A, Kawashima H, et al. Usefulness and safety of endoscopic retrograde cholangiopancreatography in children with pancreaticobiliary maljunction[J]. J Pe-diatr Surg, 2015, 50(3):377-381.
[18] 周海斌, 杨建锋, 张啸, 等. 浙江省ERCP人群特点及疾病趋势的初步研究[J]. 中华消化内镜杂志, 2019, 36(6):402-406.
Options
Outlines

/

〈 〉